Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,403.80
-2.00 (-0.14%)
Nov 9, 2026, 3:28 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.13 trillion as of November 10, 2026. It is the 1,868th most valuable company in the world and the 103rd biggest in India. Its market cap has decreased by 6.75% in one year.
Market Cap
1.13T
Enterprise Value
1.06T
Revenue
279.89B
Global Rank
Country Rank
#103 India
PE Ratio
39.16
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.13T, an increase of 74,823.15%. That is a compound annual growth rate of 24.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 1.13T | -7.10% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.74T |
| Laurus Labs | 1.26T |
| Zydus Lifesciences | 1.19T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 730.90B |
| Alkem Laboratories | 633.34B |
| Gland Pharma | 522.88B |